|
|
Effect of Guizhi Shaoyao Zhimu Decoction combined with Methotrexate in the treatment of cold-damp blockage syndrome of rheumatoid arthritis |
LU Jidi GE Xianying WANG Hailin LI Xingrui▲ |
Department of Rheumatology and Immunology, Lu’an People’s Hospital, Anhui Province, Lu’an 237005, China |
|
|
Abstract Objective To investigate the effect of Guizhi Shaoyao Zhimu Decoction combined with Methotrexate in the treatment of cold-damp blockage syndrome of rheumatoid arthritis. Methods Eighty cases of cold-damp blockage syndrome of rheumatoid arthritis patients admitted to Lu’an People’s Hospital of Anhui Province from February 2017 to May 2020 were selected and they were divided into control group and study group according to random number table method, with 40 cases in each group. The control group was treated with Methotrexate, and the study group was treated with Guizhi Shaoyao Zhimu Decoction on the basis of the control group. After two months of treatment, the clinical efficacy and the incidence of adverse reactions of the two groups were compared, and the levels of inflammatory factors and the recovery of joint function were analyzed before and after two months of treatment. Results After two months of treatment, the total effective rate of the study group was higher than that of the control group, and the difference was statistically significant (P < 0.05). After two months of treatment, the levels of C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in both groups were decreased compared with before treatment, and those in the study group were lower than those in the control group, with statistical significance (P < 0.05). After two months of treatment, the morning stiffness time, joint pain index, joint swelling number and joint tenderness number in both groups were lower than before treatment, and the study group was lower than the control group, the differences were statistically significant (P < 0.05). The total incidence of adverse reactions in the study group was lower than that in the control group, and the difference was statistically significant (P < 0.05). Conclusion Guizhi Shaoyao Zhimu Decoction combined with Methotrexate has a significant effect on cold-damp blockage syndrome of rheumatoid arthritis patients, and can significantly reduce the levels of CRP, TNF-α and IL-6, which is worthy of promotion and application.
|
|
|
|
|
[1] 胡鲲,陆耀宇,卢玉龙,等.2015-2018年黔南地区居民类风湿关节炎流行病学特征分析[J].现代预防医学,2019, 46(16):2899-2901,2913.
[2] 赵越,晏菁遥,黄闰月,等.近十年治疗类风湿关节炎文献的中医证候分布与遣方用药规律分析[J].中华中医药学刊,2019,37(9):2168-2177.
[3] 胡晓敏,宗英,余珊珊,等.类风湿关节炎治疗药物的研发进展及趋势[J].中国新药杂志,2017,26(1):36-43.
[4] 张素养,王利,刘丹,等.桂枝芍药知母汤联合甲氨蝶呤治疗类风湿性关节炎45例临床研究[J].江苏中医药,2019, 51(6):43-45.
[5] 刘雪涛,李庆.类风湿性关节炎治疗药物进展[J].现代生物医学进展,2015,15(6):1171-1173.
[6] 谢兴文,蒋国鹏,李宁,等.祛寒逐风颗粒联合西药治疗寒湿痹阻型类风湿性关节炎的临床观察[J].哈尔滨医药,2017,28(3):647-649.
[7] 中华医学会风湿病学分会.类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,4(14):265-270.
[8] 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:60-66.
[9] 国家中医药管理局.中医病症诊断疗效标准[M].南京:南京大学出版社,1994,24(5):51-52.
[10] 严广斌.视觉模拟评分法[J].中华关节外科杂志:电子版,2014,8(2):273.
[11] 刘晓微.桂枝芍药知母汤加味治疗类风湿性关节炎活动期疗效观察[J].中华中医药学刊,2017,35(2):504-507.
[12] 谢浩洋,黄月娟,王根荣,等.药熨贴治疗活动期类风湿性关节炎寒湿痹阻证的临床观察[J].中国中医药科技,2019,26(1):66-68.
[13] 池里群,周彬,高文远,等.治疗类风湿性关节炎常用药物的研究进展[J].中国中药杂志,2014,39(15):2851-2858.
[14] 董龙聪,邓路达,兰维娅,等.桂枝芍药知母汤联合常规西药对类风湿关节炎疗效的Meta分析[J].风湿病与关节炎,2018,7(11):25-31.
[15] 卢向阳,唐芳,陈琳英,等.甲氨蝶呤片联合不同抗风湿药物治疗类风湿关节炎的临床观察[J].风湿病与关节炎,2018,7(2):14-18,32.
[16] 李荣良,沈贤发,薛鸾,等.甲氨蝶呤联合硫酸羟氯喹治疗类风湿性关节炎中医不同证型疗效分析[J].河南中医,2017,37(11):1975-1977.
[17] 李雪萍,刘伟伟,郑川,等.从“络病-风药”新识桂枝芍药知母汤治疗类风湿性关节炎[J].时珍国医国药,2018, 29(2):391-393.
[18] 卢小蓉.加减桂枝芍药知母汤合益肾除湿丸治疗类风湿性关节炎的疗效分析[J].内蒙古中医药,2018,37(10):27.
[19] 张攀科,王芳,张国胜.小活络丹合桂枝芍药知母汤加减治疗风湿性关节炎寒湿痹阻证的临床观察[J].中国实验方剂学杂志,2017,23(3):181-186.
[20] 宋仙芝,王治斌,颉敏琴.颉敏琴运用桂枝芍药知母汤治疗寒热错杂型类风湿性关节炎经验[J].湖南中医杂志,2018,34(8):35-36.
[21] 赵文甲,刘维,吴沅皞.桂枝芍药知母汤治疗类风湿关节炎疗效及安全性的Meta分析[J].中国老年学杂志,2018,38(18):4435-4440.
[22] 刘志队,史丽璞.加味桂枝芍药知母汤对活动期寒热错杂型类风湿关节炎患者ESR、CRP和RF调控作用分析[J].陕西中医,2019,40(1):82-84.
[23] 惠婷,王卫.加味桂枝芍药知母汤加西药对类风湿性关节炎患者血清学指标的影响[J].贵州医药,2020,44(8):1296-1297.
[24] 于得泓,战艺,石红.雷公藤多甙片联合甲氨喋呤治疗对类风湿关节炎患者红细胞沉降率、C反应蛋白及类风湿因子的影响[J].中国医药科学,2019,9(16):90-92,157.
[25] 郑创史,邱钊禹.依那西普联合甲氨蝶呤治疗类风湿关节炎的疗效及对血清TL1A、TNF-α、IL-6以及IL-17水平的影响[J].中国药师,2016,19(4):715-717.
[26] 张佳红,周淑红,杨栋,等.四妙汤联合来氟米特治疗湿热痹阻型类风湿性关节炎临床疗效观察[J].西部中医药,2020,33(8):8-11.
[27] 李玉奎,冯传博,刘爱真,等.复方乌头微乳剂治疗活动期类风湿性关节炎寒湿痹阻证的临床疗效[J].中国实验方剂学杂志,2018,24(8):194-199. |
|
|
|